Showing results 2 to 3 of 3
< previous
Title | Author(s) | Issue Date | |
---|---|---|---|
CALGB 30601: A phase II study of dasatinib (D) in patients (pts) with previously treated malignant mesothelioma (MM) Proceeding/Conference:Journal of Clinical Oncology | 2010 | ||
Phase II study of dasatinib in patients with previously treated malignant mesothelioma (Cancer and leukemia group B 30601): A brief report Journal:Journal of Thoracic Oncology | 2012 |